Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Kura Oncology, Inc. (NASDAQ:KURA) Q3 2025 Earnings Call Transcript November 4, 2025 Kura Oncology, Inc. misses on earnings expectations. Reported EPS is $-0.84564 EPS, expectations were $-0.57.

remove-circle Internet Archive's in-browser video "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see your ...

While Visions of Mana might not have the beefiest roster in the JRPG genre, it can still be a challenge to figure out what some of the best party combinations are. That’s why we’ve done the work for ...

Abstract: This paper investigates the transient stability of the grid-forming and grid-following (GFM-GFL) paralleled system based on the Lyapunov direct method. To achieve this goal, an improved ...

KEO World Inc., a lending fintech infrastructure platform for embedded credit B2B payments, today officially entered into a binding agreement to combine its GTC business with MAHA Capital AB, a ...

Tucked within the hundreds of pages of Republican-backed cuts to taxes and the social safety net known as the “big, beautiful bill” is a $50 billion fund called the Rural Health Transformation Program ...

In Employment Division v. Smith, Justice Scalia identified the concept of hybrid rights: a restriction that targets two constitutional rights would be reviewed with heightened scrutiny. For example, a ...

Expert Rev Endocrinol Metab. 2010;5(3):331-342. Metformin also forms the cornerstone of dual therapy and is used extensively in combination with several classes of OADs. The safety and efficacy of SU ...

Abstract: Powered descent guidance is an enabling technology for extraterrestrial soft landing and reusable rocket recovery. Although the focus of guidance research has tilted toward trajectory ...

Limited evidence exists to support the simultaneous initiation of sodium–glucose cotransporter-2 inhibitors and finerenone, a nonsteroidal mineralocorticoid receptor antagonist, in persons with ...